Search

The article reports on the 80 billion euro Horizon 2020 funding package that was introduced by the European Commission that aims to improve and streamline research and innovation activities in Europe.

The article focuses on the emergence of collaboratives among pharmaceutical companies to address challenges in drug development and research and development (R&D) spending cuts. It mentions the increasing demand for new medicines for an array of diseases such as psychiatric disorders, and expectations that most of firms will reduce the R&D spending in 2012. It says that industry R&D will align along "innovation nodes" or partnerships that focus on disease, therapeutic area, or technology.

The article announces the investment plans of European firms Evonik Industries, Arkema and Badische Anilin und Soda Fabrik (BASF) in China's chemical production research and development (R&D). Evonik's plans include the building of an isophorone and isophorone diamine plant in Shanghai's Xinzhuang district while Arkema is set to build its R&D center in Changshu. BASF eyes the construction of a tert-butylamine plant in Nanjiing with an annual production capacity of 10,000 metric tons.

A letter from the editor is presented in which he examines a report from the U.S. National Science Foundation (NSF) on paying for research and development (R&D), discussing what organizations are funding R&D, what the money is actually purchasing, and the need to redistribute R&D spending.

The article reports on the cutbacks for the America COMPETES Reauthorization Act of 2010. It notes the decision of the Congress and the president to cut 917 billion dollars over the following years along with the passage of the legislation aims to increase the debt limit of the country. It is expected that most spending cuts will not be realized until January 2013 to give them enough time to campaign for issues on debt and spending.

The article focuses on the need to increase public funding for food and agriculture research and development (R&D) in the U.S. It mentions that among these R&D initiatives include renewable energy sources, improving nutrition and reducing obesity, and growth assurance on the economy. It adds that critical need to private sector research must be addressed including public oversight, public input, and global food security.

The article reports on the survey which found that professionals in the oil and gas industry are worrying over the reduced investment for the research and development (R&D).

The article provides information on the Australian government's 1.8 billion dollar program which provides tax incentives of up to 45% on spending for research and development, explains which companies are eligible, and provides resources for more information.

The article offers information on the Research and Development (R&D) Fund of the Appraisal Institute of Canada (AIC). The R&D Fund was founded as a Registered Canadian Charitable Organization that will conduct research studies on real property valuation. The AIC Board of Directors is in charge of the approval of proposals, initiatives or grants related to the R&D Fund. The process of allocating funds and the criteria for eligibility to the R&D Program are detailed.

The article reports on the economic performance of iPad tablet computers in the market. It mentions that increased demand and low prices on it extend the market substantially including schools, hospitals and small business enterprises. It also points out its influence to dedicated touch panels and aid in reducing prices as well as increase research and development investment.

The article focuses on the Procter & Gamble (P&G) Co., which reports a 14.6% gain in their profit for the fourth quarter. Bob McDonald, chairman, president, and chief executive officer of P&G, they will focus more on Asia and Africa where household are formed and seeks to provide products that improve the lives. It mentions the investment of two billion dollars in research and development (R&D). It says that the sales of beauty products of P&G declined 17%.

The article reports on the passage of several bills at the state legislature of Minnesota that took effect on July 1 and August 1, 2011. One of these laws authorizes research and innovation funding to incentivize farmers to grow corn for biofuel. Another law is the development and maintenance of a list of safety training instruction materials for school buses. The tip-sharing law enabling employers to safeguard and disburse tips based on sharing agreement is also mentioned.

The article reports on the Living Foundries program by the U.S. Defense Advanced Research Projects Agency (DARPA) as of July 2011 that would finance high-risk, cutting-edge research & development (R&D) in synthetic biology.

The article reports on the move of GlaxoSmithKline and MaRS Innovation to launch a fund devoted to pulling research out of 16 Canadian academic institutions and hospitals.

The article provides updates on several business legislation in the U.S. It states that the Small Business Regulatory Freedom Act of 2011 would reform the current federal agency rulemaking process to ensure that federal agencies adequately consider small business impact before a rule is promulgated. It relates that the American Research and Competitiveness Act would increase the amount companies can recoup for investing in research and development (R&D) from 14% to 20%.

The article focuses on the investment made by the Grape and Wine Research and Development Corp. (GWRDC) of an average of more than 20 million-dollar budget for research, development & extension (RD&E) for Australian wine sector. It states that the GWRDC, which help the sector become profitable, sustainable, and competitive was backed by winemakers, grapegrowers, and the Australian government. It mentions that GWRDC invests the said levies with the use of a five-year RD&E plan.

The article announces the new Technology Innovation Fund (TIF) launched by the National Physical Laboratory in Great Britain to assist innovative enterprises developing gas-sensing technology for environmental monitoring.

The article offers information on the technologies that help in lowering the cost of medical imaging. It states that the merchant suppliers of technologies can, in turn, enable cost reductions by amortizing their research and development costs over the entire industry, not just across the market share of one equipment manufacturer.